Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction

Preclinical studies suggest that the GABAB receptor is a potential target for treatment of substance use disorders. However, recent clinical trials report adverse effects in patients treated with the GABAB receptor agonist baclofen and even question efficacy. How can the discrepancy between preclini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vengeliene, Valentina (VerfasserIn) , Spanagel, Rainer (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 April 2018
In: Psychopharmacology
Year: 2018, Jahrgang: 235, Heft: 7, Pages: 1955-1965
ISSN:1432-2072
DOI:10.1007/s00213-018-4893-9
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00213-018-4893-9
Volltext
Verfasserangaben:Valentina Vengeliene, Tatiane T. Takahashi, Olga A. Dravolina, Irina Belozertseva, Edwin Zvartau, Anton Y. Bespalov, Rainer Spanagel

MARC

LEADER 00000caa a2200000 c 4500
001 1742349587
003 DE-627
005 20220819050224.0
007 cr uuu---uuuuu
008 201209s2018 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00213-018-4893-9  |2 doi 
035 |a (DE-627)1742349587 
035 |a (DE-599)KXP1742349587 
035 |a (OCoLC)1341382975 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Vengeliene, Valentina  |e VerfasserIn  |0 (DE-588)130680516  |0 (DE-627)505582236  |0 (DE-576)298340542  |4 aut 
245 1 0 |a Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction  |c Valentina Vengeliene, Tatiane T. Takahashi, Olga A. Dravolina, Irina Belozertseva, Edwin Zvartau, Anton Y. Bespalov, Rainer Spanagel 
264 1 |c 12 April 2018 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.12.2020 
520 |a Preclinical studies suggest that the GABAB receptor is a potential target for treatment of substance use disorders. However, recent clinical trials report adverse effects in patients treated with the GABAB receptor agonist baclofen and even question efficacy. How can the discrepancy between preclinical and clinical findings be explained? 
700 1 |a Spanagel, Rainer  |d 1961-  |e VerfasserIn  |0 (DE-588)112706312  |0 (DE-627)521941261  |0 (DE-576)289740002  |4 aut 
773 0 8 |i Enthalten in  |t Psychopharmacology  |d Berlin : Springer, 1959  |g 235(2018), 7, Seite 1955-1965  |h Online-Ressource  |w (DE-627)341342254  |w (DE-600)2066933-1  |w (DE-576)255486898  |x 1432-2072  |7 nnas  |a Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction 
773 1 8 |g volume:235  |g year:2018  |g number:7  |g pages:1955-1965  |g extent:11  |a Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction 
856 4 0 |u https://doi.org/10.1007/s00213-018-4893-9  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201209 
993 |a Article 
994 |a 2018 
998 |g 112706312  |a Spanagel, Rainer  |m 112706312:Spanagel, Rainer  |d 60000  |e 60000PS112706312  |k 0/60000/  |p 7  |y j 
999 |a KXP-PPN1742349587  |e 3820911286 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Valentina Vengeliene, Tatiane T. Takahashi, Olga A. Dravolina, Irina Belozertseva, Edwin Zvartau, Anton Y. Bespalov, Rainer Spanagel"]},"person":[{"family":"Vengeliene","display":"Vengeliene, Valentina","given":"Valentina","role":"aut"},{"display":"Spanagel, Rainer","role":"aut","given":"Rainer","family":"Spanagel"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1742349587","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"12 April 2018"}],"physDesc":[{"extent":"11 S."}],"id":{"eki":["1742349587"],"doi":["10.1007/s00213-018-4893-9"]},"relHost":[{"disp":"Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addictionPsychopharmacology","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1432-2072"],"zdb":["2066933-1"],"eki":["341342254"]},"note":["Gesehen am 14.07.06"],"titleAlt":[{"title":"Psychopharmacologia"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Springer ; Springer","dateIssuedDisp":"1959-","dateIssuedKey":"1959","publisherPlace":"Berlin ; Heidelberg ; New York, NY ; Berlin ; Heidelberg [u.a.]"}],"recId":"341342254","pubHistory":["1.1959/60 -"],"title":[{"title_sort":"Psychopharmacology","title":"Psychopharmacology"}],"language":["eng"],"part":{"pages":"1955-1965","extent":"11","issue":"7","volume":"235","year":"2018","text":"235(2018), 7, Seite 1955-1965"}}],"note":["Gesehen am 09.12.2020"],"title":[{"title_sort":"Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction","title":"Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction"}],"language":["eng"]} 
SRT |a VENGELIENEEFFICACYAN1220